Neutrophils pretreated with granulocyte colony-stimulating factor (G- CSF) are not related to the severity of endotoxin-induced lung injury

Experimental Lung Research

Volumn 23, Issue 5, 1997, Pages 393-404

  Koizumi, Tomonobu ^a   Kubo, Keishi ^a   Koyama, Shigeru ^a   Hanaoka, Masayaku ^a   Hayano, Toshihide ^a   Miyahara, Takayuki ^a   Kobayashi, Toshio ^a   Sekiguchi, Morie ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lung lymph flow; Pulmonary hypertension; Pulmonary permeability; Sheep

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENDOTOXEMIA; LEUKOCYTE ACTIVATION; LUNG HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHEEP;

EID: 0030861074     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149709039234     Document Type: Article

References (35)

1. Weiland JE, Davis WB, Holter JK, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathological significance. Am Rev Respir Dis. 1986;133:218-225.
2. Zimmerman GA, Renzetti AD, Hill HR. Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome: evidence for activated neutrophils in the pulmonary circulation. Am Rev Respir Dis. 1983;127:290-300.
3. Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome: evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest. 1983;71:754-761.
4. Idell S, Kucich U, Fein A, et al. Neutrophil-elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:1098-1105.
5. Heflin AC, Brigham KL. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest. 1981;68:1253-1260.
6. Worthen GS, Haslett C, Rees AJ, Gumbay RS, Hensen JE, Henson PM. Neutrophil-mediated pulmonary vascular injury; synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis. 1987;136:19-28.
7. Meyrick B, Brigham KL. Acute effects of Escherichia coli endotoxin on the pulmonary microcirculartion of anesthetized sheep: structure-function relationships, Lab Invest. 1983;48:558-570.
8. Brigham KL, Meryick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986;133:913-927.
9. Snapper J, Bernard G, Hinson J, et al. Endotoxemia induced leukopenia in sheep: correlation with lung vascular permeability and hypoxemia but not with pulmonary hypertension. Am Rev Respir Dis. 1983;127:306-309.
10. Kamen R, Clark S. The human hematopoietic colony-stimulating factors. Science. 1987;236:1229-1237.
11. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986;232:61-65.
12. Eguchi K, Shinkai T, Sasaki V, et al. Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer. Jpn J Cancer Res. 1990;81:1168-1174.
13. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell cancer. N Engl J Med. 1991;325:164-170.
14. Wang JM, Chen ZG, Colella S, et al. Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood. 1988;72:1456-1460.
15. Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takaku F. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun. 1987;144:1143-1146.
16. Ohsaka A, Kitagawa S, Sakamoto S, et al. In vivo activation of human neutrophil function by administration of recombinant human granulocyte colony-stimulating factor in patient with malignant lymphoma. Blood. 1989;74:2743-2748.
17. Yuo A, Kitagawa S, Ohsaka A, et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: polentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood. 1989;74:2144-2149.
18. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis. 1991;163:579-583.
19. Abraham E, Stevens P. Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage. Crit Care Med. 1992;20:1127-1133.
20. Hebert JC, Oreilly M, Camelli RL. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg. 1990;125:1075-1078.
21. Fink MP, O'Sullivan BP, Menconi MJ, et al. Effects of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma. 1993;34:571-578.
22. Kanazawa M, Ishizaka A, Hasegawa N, Suzuki Y, Yokoyama T. Granulocyte colony-stimulating factor does not enhance endotoxin induced lung injury in guinea pigs. Am Rev Respir Dis. 1992;145:1030-1035.
23. Terashima T, Kanazawa M, Sayama K, et al. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am J Respir Crit Care Med. 1994;149:1295-1303.
24. Eichacker PQ, Waisman Y, Natanson C, et al. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol. 1994;77:2366-2373.
25. Koizumi T, Kubo K, Shinozaki S, Koyama S, Kobayashi T, Sekiguchi M. Granulocyte colony-stimulating factor does not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis. 1993;148:132-137.
26. Staub NC, Bland RD, Brigham KL, Demling R, Drdman AJ III, Woolverton VVC. Preparation of chronic lung lymph fistulas in sheep. J Surg Res. 1975;19:315-320.
27. Kubo K, Kobayashi T. Effects of OKY-046, a selected thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unauesthetized sheep. Am Rev Respir Dis. 1985;132:494-499.
28. Bradley JD, Roselli RJ, Parker RE, Harris TR. Effects of endotoxemia on the sheep lung microvascular membrane: a two-pore theory. J Appl Physiol. 1988;64:2675-2683.
29. Said SI, Foda HD. Pharmacologic modulation of lung injury. Am Rev Respir Dis. 1988;139:1553-1564.
30. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991;144:268-271.
31. Chollet-Martin S, Montravers P, Gibert C, et al. Subpopulation of hyperresponsive polymorphonuclear neurophils in patients with adult respiratory distress syndrome; role of cytokine production. Am Rev Respir Dis. 1992;146:990-998.
32. Stephens KK, Isbizaka A, Wu Z, Larrick JW, Raffin TA. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am Rev Respir Dis. 1988;138:1300-1307.
33. Gorgen I, Hartung T, Leist M, et al. Gramulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol. 1992;149:918-924.
34. Horvath CJ, Ferro TJ, Jesmok G, Malik AB. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci USA. 1988;85:9219-9223.
35. King J, Deboisblanc BP, Mason DM, et al. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med. 1995;151:302-309.